ICU Medical, Inc.
ICUI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 3.64 | -0.07 | 1.57 | 1.42 |
| FCF Yield | 1.01% | -0.33% | 1.08% | 0.36% |
| EV / EBITDA | 289.78 | 40.99 | 69.84 | 58.72 |
| Quality | ||||
| ROIC | 0.48% | 0.28% | 0.20% | -2.94% |
| Gross Margin | 37.41% | 37.91% | 34.75% | 36.08% |
| Cash Conversion Ratio | -16.70 | 0.32 | -3.32 | -1.69 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.04% | 1.13% | 1.63% | 1.47% |
| Free Cash Flow Growth | 377.37% | -129.41% | 170.00% | -36.92% |
| Safety | ||||
| Net Debt / EBITDA | 73.93 | 10.38 | 19.40 | 15.25 |
| Interest Coverage | -0.69 | 0.46 | 0.44 | 1.44 |
| Efficiency | ||||
| Inventory Turnover | 0.54 | 0.55 | 0.67 | 0.69 |
| Cash Conversion Cycle | 152.78 | 154.16 | 123.96 | 126.59 |